BaseLaunch
Investor profile
Venture capital
BaseLaunch has backed 3 European tech companies across 3 funding rounds in 2022, joining rounds totalling €1.4M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2022
1 yr
Total round €
€1.4M
sum of rounds joined
Deals by year
distinct rounds / yearBaseLaunch — deals by year — interactive chart.
Data table
| BaseLaunch — deals by year | |
|---|---|
| 2022 | 3 |
Top sectors
by dealsBaseLaunch — top sectors — interactive chart.
Data table
| BaseLaunch — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsBaseLaunch — stages — interactive chart.
Data table
| BaseLaunch — stages | |
|---|---|
| Other | 3 |
Countries
by dealsBaseLaunch — countries — interactive chart.
Data table
| BaseLaunch — countries | |
|---|---|
| Switzerland | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsNo co-investors found.
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Stromal Therapeutics | Switzerland | 1 | €481k |
| Aukera Therapeutics | Switzerland | 1 | €481k |
| Engimmune Therapeutics | Switzerland | 1 | €481k |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Stromal Therapeutics | Other | €481k | 2022-02 |
| Aukera Therapeutics | Other | €481k | 2022-02 |
| Engimmune Therapeutics | Other | €481k | 2022-02 |